ENDRA Life Sciences (NDRA) Stock Price Down 20.8%

Shares of ENDRA Life Sciences Inc (NASDAQ:NDRA) traded down 20.8% during mid-day trading on Thursday . The stock traded as low as $2.27 and last traded at $2.32. 967,206 shares changed hands during trading, an increase of 491% from the average session volume of 163,696 shares. The stock had previously closed at $2.93.

ENDRA Life Sciences (NASDAQ:NDRA) last posted its quarterly earnings data on Monday, November 5th. The company reported ($0.63) earnings per share (EPS) for the quarter. ENDRA Life Sciences had a negative return on equity of 394.07% and a negative net margin of 114.33%.

In related news, major shareholder Longboard Capital Advisors, Ll sold 130,200 shares of the stock in a transaction that occurred on Wednesday, October 24th. The stock was sold at an average price of $4.19, for a total value of $545,538.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 12.70% of the company’s stock.

An institutional investor recently bought a new position in ENDRA Life Sciences stock. ICM Asset Management Inc. WA acquired a new stake in ENDRA Life Sciences Inc (NASDAQ:NDRA) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 130,870 shares of the company’s stock, valued at approximately $400,000. ICM Asset Management Inc. WA owned 3.31% of ENDRA Life Sciences at the end of the most recent quarter. 5.76% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.chaffeybreeze.com/2018/12/07/endra-life-sciences-ndra-stock-price-down-20-8.html.

ENDRA Life Sciences Company Profile (NASDAQ:NDRA)

ENDRA Life Sciences Inc develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding.

Featured Story: Outstanding Shares

Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply